Rittirsch Daniel, Hoesel L Marco, Ward Peter A
Department of Pathology, University of Michigan Medical School, 1301 Catherine Road, Ann Arbor, MI 48109-0602, USA.
J Leukoc Biol. 2007 Jan;81(1):137-43. doi: 10.1189/jlb.0806542. Epub 2006 Oct 4.
Frequently used experimental models of sepsis include cecal ligation and puncture, ascending colon stent peritonitis, and the i.p. or i.v. injection of bacteria or bacterial products (such as LPS). Many of these models mimic the pathophysiology of human sepsis. However, identification of mediators in animals, the blockade of which has been protective, has not translated into clinical efficacy in septic humans. We describe the shortcomings of the animal models and reasons why effective therapy for human sepsis cannot be derived readily from promising findings in animal sepsis.
常用的脓毒症实验模型包括盲肠结扎和穿刺、升结肠支架性腹膜炎,以及腹腔内或静脉内注射细菌或细菌产物(如脂多糖)。其中许多模型模拟了人类脓毒症的病理生理学。然而,在动物中已证实具有保护作用的介质阻断剂,在脓毒症患者中并未转化为临床疗效。我们描述了动物模型的缺点,以及为何不能轻易从动物脓毒症的有前景的研究结果中得出针对人类脓毒症的有效治疗方法的原因。